Sales & Marketing News | pharmaphorum

News

Jazz has reached an agreement to buy Chimerix for around $935 million, adding a brain cancer drug heading for an FDA approval decision in August.

News

FDA starts a review of Roche's Gazyva as a treatment for lupus nephritis, an indication that analysts think could unlock renewed sales growth.

News

Things will get tougher before they get better at Bayer, according to CEO Bill Anderson, as the group reports its 2024 financial results.

News

The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto.

News

Genentech has won FDA approval for its clot-buster TNKase as a treatment for acute ischaemic stroke, after almost abandoning the project in 2023.

News

The UK pharma industry has warned that declining access to new medicines in England will undermine the government's efforts to rebuild the NHS.